CHU de Reims
chu-reims.frTotal trials
273
Active
46
Phase 3
9
Total enrollment
71,283
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Injection of 500 mg magnesium sulfate + 2 mg morphine into the epidural space | — | — | — | — | — | 1 | |
| Injection of Isotonic saline + 2 mg morphine into the epidural space | — | — | — | — | — | 1 | |
| PCR multiplex by FilmArray | — | — | — | — | — | 1 | |
| Triamcinolone Acetonide | — | — | — | — | — | 1 | |
| saline solution | — | — | — | — | — | 1 | |
| Blood sampling | — | — | — | — | — | 1 | |
| Liquid bubble sampling | — | — | — | — | — | 1 | |
| Blood sampling & Chest CT without | — | — | — | — | — | 1 | |
| blood test | — | — | — | — | — | 1 | |
| microbiology | — | — | — | — | — | 1 | |
| histology | — | — | — | — | — | 1 |
Next readouts
- 2025-01-10
- 2026-11
- 2027-01-07
- 2027-01-11
- 2027-07
- 2028-06
Top conditions
- Bullous Pemphigoid6
- Alzheimer Disease4
- Pregnancy4
- Bipolar Disorder4
- Obesity4
- Hidradenitis Suppurativa3
- Periodontitis3
- Gingivitis3
Frequently asked questions about CHU de Reims
- How many clinical trials does CHU de Reims have on ClinicalTrials.gov?
- CHU de Reims is listed as the lead sponsor on 273 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of CHU de Reims's trials are in Phase 3?
- 9 of CHU de Reims's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does CHU de Reims focus on?
- CHU de Reims's most-studied conditions on ClinicalTrials.gov are Bullous Pemphigoid, Alzheimer Disease, Pregnancy, Bipolar Disorder, Obesity.
- When are CHU de Reims's next clinical trial readouts?
- CHU de Reims has 6 upcoming primary-completion readouts tracked here; the soonest is “Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid”, expected around 2025-01-10.